Oncolytics Biotech Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
0.00 |
| Income |
-14.74 Mil |
| Net Profit Margin |
NA |
| Return on Equity |
-176.32% |
| Debt/Equity Ratio |
0.00 |
|
| Revenue/Share |
0.00 |
| Earnings/Share |
-0.32 |
| Book Value/Share |
0.13 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 0.0 | 0.0 | 0.0 |
| 2nd Qtr | 0.0 | 0.0 | 0.0 |
| 3rd Qtr | 0.0 | 0.0 | 0.0 |
| 4th Qtr | NA | 0.0 | 0.0 |
| Total | 0.0 | 0.0 | 0.0 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.08 | -$0.08 | -$0.10 |
| 2nd Qtr | -$0.09 | -$0.12 | -$0.09 |
| 3rd Qtr | -$0.05 | -$0.09 | -$0.09 |
| 4th Qtr | NA | -$0.10 | -$0.09 |
| Total | -$0.22 | -$0.39 | -$0.37 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 20% | 11% | --- |
| 2nd Qtr | -13% | -50% | 10% |
| 3rd Qtr | 44% | 25% | 0% |
| 4th Qtr | NA | -11% | 0% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | 0% | 20% |
| 2nd Qtr | 25% | -33% |
| 3rd Qtr | 44% | 0% |
| 4th Qtr | NA | -11% |
advertisement
Recent News